Exploring Ibogaine. To explore a different substance…

Names:
Ibogaine
A complexly substituted tryptamine
IUPAC name:
12-Methoxyibogamine
5025 · C20H26N2O · 310.433
InChI=1S/C20H26N2O/c1-3-13-8-12-9-17-19-15(6-7-22(11-12)20(13)17)16-10-14(23-2)4-5-18(16)21-19/h4-5,10,12-13,17,20-21H,3,6-9,11H2,1-2H3/t12-,13+,17+,20+/m1/s1
HSIBGVUMFOSJPD-CFDPKNGZSA-N This stereoisomer Any stereoisomer

Naranjo, C. Psychotherapeutic Possibilities of New Fantasy-Enhancing Drugs. Clin. Toxicol., 1 Jan 1969, 2 (2), 209–224. 855 kB. https://doi.org/10.3109/15563656908990930

Naranjo, C. Ibogaine: Fantasy and reality. In The Healing Journey: New approaches to consciousness; , Pantheon Books, New York, 1974; pp 174–228.

Ray, TS. Psychedelics and the human receptorome. PLOS ONE, 2 Feb 2010, 5 (2), e9019. 791 kB. https://doi.org/10.1371/journal.pone.0009019

Shulgin, AT. Chemistry and structure-activity relationships of the psychotomimetics. In Psychotomimetic Drugs; Efron, DH, Ed., Raven Press, New York, 1970; pp 21–41. 8.6 MB.

Meyer, MR; Caspar, A; Brandt, SD; Maurer, HH. A qualitative/quantitative approach for the detection of 37 tryptamine-derived designer drugs, 5 β-carbolines, ibogaine, and yohimbine in human urine and plasma using standard urine screening and multi-analyte approaches. Anal. Bioanal. Chem., 1 Jan 2014, 406 (1), 225–237. 457 kB. https://doi.org/10.1007/s00216-013-7425-9

O-2446
822
1173
23 June 2018 · Creative Commons BY-NC-SA ·